Here are four points:
1. The company traded 172,720 shares.
2. Integra LifeSciences has a 50-day moving average of $65.38 and 200-day moving average of $62.86.
3. The market capitulation is $2.45 billion.
4. The company’s 52-week low registers at $52.72 and the 52-week high is $68.84.
More articles on devices:
Amedica, SI-BONE, Stryker & more: 14 key notes
Stryker completes CareFusion’s VCF acquisition: 5 takeaways
FDA panel finds Cartiva SCI safe, effective: 3 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
